BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, July 13, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Other news to note for Jan. 23, 2026

Jan. 23, 2026
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Cvrx, Spinal Resources.
Read More

Regulatory actions for Jan. 23, 2026

Jan. 23, 2026
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Clearpoint Neuro, Medtronic, Rhythm AI.
Read More

Appointments and advancements for Jan. 22, 2026

Jan. 22, 2026
New hires and promotions in the biopharma industry, including: Angelini, Crystalys, Human Continuum, LB, Ocular, Odyssey, Variant Bio, Zura.
Read More

Regulatory actions for Jan. 22, 2026

Jan. 22, 2026
Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Intrabio, Ionis, Opna, Otsuka, Ouro, Scynexis, Veloxis, Wugen.
Read More

Other news to note for Jan. 22, 2026

Jan. 22, 2026
Biopharma happenings, including deals and partnerships, and other news in brief: Genentech, Hygtia, Immedica, Insilico, Lisata, Kuva, Neurocrine, Qilu.
Read More

Financings for Jan. 22, 2026

Jan. 22, 2026
Biopharmas raising money in public or private financings, including: Engene, Ervimmune, Ocugen, Think, Vivos.
Read More

Appointments and advancements for Jan. 22, 2026

Jan. 22, 2026
New hires and promotions in the med-tech industry, including: Akido Labs, Axis Care, Clairity, Heartbeam, Human Continuum, Pixee Medical, Prelude Dx.
Read More

Financings for Jan. 22, 2026

Jan. 22, 2026
Med-tech firms raising money in public or private financings, including: Axogen
Read More

In the clinic for Jan. 22, 2026

Jan. 22, 2026
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Hyperfine, Herowear, Kardium, Natera, Quanterix.
Read More

Other news to note for Jan. 22, 2026

Jan. 22, 2026
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Axion Biosystems, Biotissue, Concept Medical, Cerus, Cytotronics, Integrity Orthopaedics, Qure.ai, Reflexion, Smith + Nephew, Spotitearly.
Read More
Previous 1 2 … 76 77 78 79 80 81 82 83 84 … 1820 1821 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 13, 2026.
  • Silhouette with keyhole

    FENS 2026: Next-gen biologics take on brain disease

    BioWorld
    Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
  • Wainua autoinjector

    Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy

    BioWorld
    News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
  • Modius Spero wearable neuromodulation device

    Neurovalens granted FDA approval for PTSD therapy for US veterans

    BioWorld
    Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
  • NRF2 activators reported in Vailima Peninsula patent

    BioWorld Science
    Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing